Product Information
TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB is a generic product labeled by Solco Healthcare US LLC, priced at $0.3231 per EA under NDC 43547044203. Its NADAC has been published 417 times since Aug 29, 2018.
FDA first approved this application on Nov 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5; 80 mg/1; mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547044203
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA209028FDA Approved
11/6/2017
TE Code
AB
On Market Since
2/5/2018
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB has been published 417 times since Aug 29, 2018, and over the history we have for it it has declined 80.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3231 per EA |
|---|---|
| All-time high | $1.7437 (Aug 12, 2020) |
| All-time low | $0.3231 (Aug 19, 2026) |
| 52-week high | $0.4121 |
| 52-week low | $0.3231 |
| Median price | $0.8996 |
| Average price | $0.9510 |
| Largest weekly change | +59.1% (Dec 20, 2023) |
| Weeks tracked | 417 |
| Tracking since | Aug 29, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB, manufactured by Solco Healthcare US LLC, is $0.3231 per EA (NDC 43547044203), effective Aug 19, 2026.
How has the price of TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB has declined 80.2%. It has been tracked across 417 weekly CMS publications since Aug 29, 2018.
What are the highest and lowest recorded NADAC prices for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB?
Since Aug 29, 2018, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB has ranged from a low of $0.3231 (Aug 19, 2026) to a high of $1.7437 (Aug 12, 2020), with a median of $0.8996 per EA.
Are there cheaper alternatives to TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB?
TELMISARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TB (NDC 43547044203) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.